Artelo Biosciences regains Nasdaq minimum bid price compliance

ARTELO BIOSCIENCES, INC.

Received Nasdaq letter confirming compliance with Listing Rule 5550(a)(2) on August 24, 2022.
Common stock bid price closed at or above $1.00 for required period, closing the matter.
Company avoids potential delisting risk from Nasdaq.

item 8.01

ARTELO BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001640334-22-001896

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.